Smidt Heart Institute at Cedars-Sinai | sciencenewsnet.in

Breaking News

Substudy of ADVOCATE Trial for ANCA-Associated Vasculitis Finds Avacopan Reduces Need for Glucocorticoids, Respiratory and ENT Involvement

Nearly Half of Patients at High Risk for Lung Cancer Delayed Screening Follow-Up

Time-restricted eating may lower CVD risk for older breast cancer survivors

American Thoracic Society Announces Leadership for 2022-2023

Private insurers paid hospitals 224% of what Medicare would in 2020

COVID-19’s devastating toll: An rise in adolescent mental health crises and suicidality

Aging well in a pandemic: Older adults share what it takes

Impact of Potential NATO Expansion on International Business, Affairs and Trade

For Plasma with a Hot Core and Cool Edges, Super-H Mode Shows Promise

Study Determines Orgasmic Meditation Is More Comparable to Meditation Than Sex

18 May, 2022

Heart Experts Available to Discuss Approval of New Heart Drug

April 29, 2022 sarah JonasFeature

Today, the Food and Drug Administration (FDA) announced the approval of mavacamten, a new drug shown to provide relief to obstructive hypertrophic cardiomyopathy patients experiencing shortness of breath.

Cardiologists, Cardiothoracic Surgeons Available for Expert Commentary Ahead of Upcoming Conferences

April 27, 2022 sarah JonasFeature Expert

Cardiologists and cardiothoracic surgeons from the Smidt Heart Institute at Cedars-Sinai are available to discuss the latest advances in research, clinical care, transcatheter procedures and cardiothoracic surgery throughout the International Society for Heart and Lung Transplantation (ISHLT) Scientific Sessions 2022 and Heart Rhythm 2022.